Glucocorticoids for acute viral bronchiolitis in infants and young children

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Fernandes, Ricardo M ^a,b   Bialy, Liza M ^c   Vandermeer, Ben ^c   Tjosvold, Lisa ^d   Plint, Amy C ^e   Patel, Hema ^f   Johnson, David W ^g   Klassen, Terry P ^h   Hartling, Lisa ^c  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f MONTREAL CHILDREN S HOSPITAL   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; DEXAMETHASONE; EPINEPHRINE; GLUCOCORTICOID; IPRATROPIUM BROMIDE; PLACEBO; PREDNISOLONE; PREDNISONE; SALBUTAMOL; ADRENALIN;

BLEEDING; CHICKENPOX; CHILD; CHILDHOOD DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INFANT; LENGTH OF STAY; LUNG FUNCTION; PALLOR; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREMOR; VIRAL BRONCHIOLITIS; VOMITING; ACUTE DISEASE; AMBULATORY CARE; BRONCHIOLITIS, VIRAL; HOSPITALIZATION; META ANALYSIS; NEWBORN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY SOUNDS;

ACUTE DISEASE; AMBULATORY CARE; BRONCHIOLITIS, VIRAL; DEXAMETHASONE; EPINEPHRINE; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY SOUNDS;

EID: 84891681931     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004878.pub4     Document Type: Review

References (213)

1. Barlas C, Kiper N, Göçmen A, Ozçelik U, Dilber E, Anadol D, et al.Racemic adrenaline and other treatment regimens in mild and moderate bronchiolitis. Cocuk Sagligi Ve Hastaliklari Dergisi 1998;41(2):155-66.
2. Barlas C, Kiper N, Göçmen A, Ozçelik U, Dilber E, Anadol D, et al.Racemic adrenaline and other treatment regimens in mild and moderate bronchiolitis. Cocuk Sagligi Ve Hastaliklari Dergisi 1998;41(2):155-66.
3. Barlas C, Kiper N, Göçmen A, Ozçelik U, Dilber E, Anadol D, et al.Racemic adrenaline and other treatment regimens in mild and moderate bronchiolitis. Cocuk Sagligi Ve Hastaliklari Dergisi 1998;41(2):155-66.
4. Bentur L, Shoseyov D, Feigenbaum D, Gorichovsky Y, Bibi H. Dexamethasone inhalations in RSV bronchiolitis: a double-blind, placebo-controlled study. Acta Paediatrica 2005;94(7):866-71.
5. Berger I, Argaman Z, Schwartz SB, Segal E, Kiderman A, Branski D, et al.Efficacy of glucocorticoids in acute bronchiolitis: short-term and long-term follow-up. Pediatric Pulmonology 1998;26:162-6.
6. Cade A, Brownlee KG, Conway SP, Haigh D, Short A, Brown J, et al.Randomised placebo controlled trial of nebulised glucocorticoids in acute respiratory syncytial viral bronchiolitis. Archives of Disease in Childhood 2000;82(2):126-30.
7. Corneli HM, Zorc JJ, Mahajan P, Shaw KN, Holubkov R, Reeves SD, et al.A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. New England Journal of Medicine 2007;357(4):331-9.
8. De Boeck K, Van der Aa N, Van Lierde S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. Journal of Pediatrics 1997;131(6):919-21.
9. Goebel J, Estrada B, Quinonez J, Nagi N, Sanford D, Boerth RC. Prednisolone plus albuterol versus albuterol alone in mild to moderate bronchiolitis. Clinical Pediatrics 2000;39(4):213-20.
10. Gomez-y-Lopez RE, Hernandez-Sierra JF, Torres-Ruvalcaba BA, Martinez-Puente E, del Carmen Martinez-Garcia M. Comparative clinical study of dexamethasone vs. nebulized salbutamol in acute bronchiolitis. Gaceta Medica de Mexico 2007;143(3):189-92.
11. Klassen TP, Sutcliffe T, Watters LK, Wells GA, Allen UD, Li MM. Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. Journal of Pediatrics 1997;130(2):191-6.
12. Kuyucu S, Unal S, Kuyucu N, Yilgor E. Additive effects of dexamethasone in nebulized salbutamol or L-epinephrine treated infants with acute bronchiolitis. Pediatrics International 2004;46(5):539-44.
13. Kuyucu S, Unal S, Kuyucu N, Yilgor E. Additive effects of dexamethasone in nebulized salbutamol or L-epinephrine treated infants with acute bronchiolitis. Pediatrics International 2004;46(5):539-44.
14. Kuyucu S, Unal S, Kuyucu N, Yilgor E. Additive effects of dexamethasone in nebulized salbutamol or L-epinephrine treated infants with acute bronchiolitis. Pediatrics International 2004;46(5):539-44.
15. Mesquita M, Castro-Rodriguez JA, Heinichen L, Fariña E, Iramain R. Single oral dose of dexamethasone in outpatients with bronchiolitis: a placebo controlled trial. Allergologia et Immunopathologia 2009;37(2):63-7.
16. Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al.Epinephrine and dexamethasone in children with bronchiolitis. New England Journal of Medicine 2009;360(1533-4406):2079-89.
17. Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al.Epinephrine and dexamethasone in children with bronchiolitis. New England Journal of Medicine 2009;360(1533-4406):2079-89.
18. Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al.Epinephrine and dexamethasone in children with bronchiolitis. New England Journal of Medicine 2009;360(1533-4406):2079-89.
19. Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. Journal of Pediatrics 1998;132(5):849-53.
20. Roosevelt G, Sheehan K, Grupp-Phelan J, Tanz RR, Listernic R. Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet 1996;348(9023):292-305.
21. Schuh S, Coates AL, Binnie R, Allin T, Goia C, Corey M, et al.Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. Journal of Pediatrics 2002;140:27-32.
22. Teeratakulpisarn J, Limwattananon C, Tanupattarachai S, Limwattananon S, Teeratakulpisarn S, Kosalaraksa P. Efficacy of dexamethasone injection for acute bronchiolitis in hospitalized children: a randomized, double-blind, placebo-controlled trial. Pediatric Pulmonology 2007;42(5):433-9.
23. Zhang L, Ferruzzi E, Bonfanti T, Auler MI, D'Avila NE, Faria CS, et al.Long and short-term effect of prednisolone in hospitalized infants with acute bronchiolitis. Journal of Paediatrics and Child Health 2003;39(7):548-51.
24. Anonymous. Inhaled steroids and recurrent wheeze after bronchiolitis. Lancet 1989;1(8645):999-1000.
25. Bacharier LB, Phillips BR, Zeiger RS, Szefler SJ, Martinez FD, Lemanske RFJr, et al.Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. Journal of Allergy & Clinical Immunology 2008;122(6):1127-35.
26. Bai J, Xu PR. Montelukast in the treatment of bronchiolitis, a multi-center, randomized, three-blind, placebo-controlled trial. Chinese Journal of Evidence-Based Medicine 2010;10:1011-5.
27. Berger I. A double-blind placebo-controlled study on the efficacy of corticosteroids in infants with bronchiolitis. European Respiratory Journal 1996;9(Suppl 23):246.
28. Bibi H. A double blind study to determine the benefit of inhaled corticosteroids in bronchiolitis. European Respiratory Journal 2004;24(Suppl 48):A282.
29. Blom D, Ermers M, Bont L, van Aalderen WM, van Woensel JB. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004881.pub3]
30. Bont L, Kimpen JL, Ermers MJ. Inhaled corticosteroids and children. New England Journal of Medicine 2006;355(6):624-5.
31. Buckingham SC, Jafri HS, Bush AJ, Carubelli CM, Sheeran P, Hardy RD, et al.A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. Journal of Infectious Diseases 2002;185(9):1222-8.
32. Bülow SM, Nir M, Levin E, Friis B, Thomsen LL, Nielson JE, et al.Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999;104(6):e77.
33. Callen Blecua M, Aizpurua Galdeano P, Ozcoidi Erro I, Mancisidor Aguinagalde L, Guedea Adiego C, Busselo Ortega E, et al.Inhaled corticosteroids and wheezing post-bronchiolitis. Anales Españoles de Pediatría 2000;52(4):351-5.
34. Chao LC, Lin YZ, Wu WF, Huang FY. Efficacy of nebulized budesonide in hospitalized infants and children younger than 24 months with bronchiolitis. Acta Paediatrica Taiwan 2003;44(6):332-5.
35. Chipps BE. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. Pediatrics 2008;122(Suppl 4):215.
36. Connolly JH, Field CMB, Glasgow JFT, Slattery CM, MacLynn DM. A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta Paediatrica Scandinavica 1969;58(2):116-20.
37. Cornell HM, Zorc JJ, Majahan P, Shaw KN, Holubkov R, Reeves SD, et al.Does dexamethasone improve bronchiolitis in infants?. Journal of Family Practice 2007;56(11):890.
38. Csonka P, Kaila M, Laippala P, Iso-Mustajarvi M, Vesikari T, Ashorn P. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. Journal of Pediatrics 2003;143(6):725-30.
39. Dabbous IA, Tkachyk JS, Stamm SJ. A double blind study on the effects of corticosteroids in the treatment of bronchiolitis. Pediatrics 1966;37(3):477-84.
40. da Silva ML. Effectiveness and Safety of Budesonide Nebulised in Control of Acute Crisis of Wheezing in Children Under Three Years not Responsive to Fenoterol [Dissertation]. São Paulo, SP: Universidade Estadual Paulista, 2007.
41. Daugbjerg P, Brenoe E, Forchhammer H, Frederiksen B, Glazowski MJ, Ibsen KK, et al.A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatrica 1993;82(6-7):547-51.
42. Dennis J. Steroids in the treatment of obstructive bronchiolitis. Southern Medical Journal 1963;56:1436.
43. Doornebal N, Brand PL. Children younger than 1 year with acute dyspnea and wheezing: don't prescribe oral corticosteroids. Nederlands Tijdschrift voor Geneeskunde 2009;153(10):440-2.
44. Ermers M, Rovers M, Woensel J, Kimpen J, Bont L. High-dose inhaled corticosteroids prevent wheeze following respiratory syncytial virus infection: a randomized double-blind placebo-controlled trial. European Respiratory Journal 2008;32(Suppl 52):720.
45. Ermers MJJ, Rovers MM, Van Woensel JB, Kimpen JLL, Bont LJ. The effect of high dose inhaled corticosteroids on wheeze in infants after respiratory syncytial virus infection: randomised double blind placebo controlled trial. BMJ 2009;338:996.
46. Filippskii GK, Tkacheva NV, Raozhina VI, Ivanov NN, Filimonova II. Possibilities of using glucocorticoid therapy for acute bronchiolitis in very young children. Pediatriia 1983;8:71-3.
47. Fox GF, Everard ML, Marsh MJ, Milner AD. Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Archives of Disease in Childhood 1999;80(4):343-7.
48. Garrison MM, Christakis DA, Harvey E, Cummings P, Lavis RL. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 2000;105(4):e44.
49. Gerasymov S. High-dose vs low-dose nebulized budesonide suspension in a sleeping infant with bronchiolitis [Abstract]. European Respiratory Society Annual Congress Abstract Book. 2010:[E3461].
50. Hall CB. Dexamethasone of no benefit in moderate-to-severe bronchiolitis. Journal of Pediatrics 2008;152(1):143-4.
51. Hoekstra MO, Kapitein B, Van Der Ent CK, Arets HGM. Are inhaled corticosteroids safe and effective in infants with asthma-like symptoms?. Pediatrics 2004;114(1):325.
52. Jartti T, Vanto T, Heikkinen T, Ruuskanen O. Systemic glucocorticoids in childhood expiratory wheezing: relation between age and viral etiology with efficacy. Pediatric Infectious Disease Journal 2002;21(9):873-8.
53. Jartti T, Lehtinen P, Vanto T, Hartiala J, Vuorinen T, Makela MJ, et al.Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus. Pediatric Infectious Disease Journal 2006;25(6):482-8.
54. Jartti T, Lehtinen P, Vanto T, Vuorinen T, Hiekkanen H, Hartiala J, et al.Atopic characteristics of wheezing children and responses to prednisolone. Pediatric Pulmonology 2007;42(12):1125-33.
55. Jartti T, Soderlund-Venermo M, Allander T, Vuorinen T, Hedman K, Ruuskanen O. No efficacy of prednisolone in acute wheezing associated with human bocavirus infection. Pediatric Infectious Disease Journal 2011;30:521-3.
56. Kajosaari M, Syvanen P, Forars M, Juntunen-Backman K. Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma. Pediatric Allergy and Immunology 2000;11(3):198-202.
57. Karaatmaca B, Aydoan M, Piraneci R, Bicnuller S. Comparison of the effectiveness of nebulized budesonide, salbutamol and adrenaline in the treatment of acute bronchiolitis: a randomized double blind placebo controlled clinical trial. Allergy: European Journal of Allergy and Clinical Immunology 2010;65(Suppl 92):716-7.
58. Kelm-Kahl I. A single dose of corticosteroids has no influence on the rate of hospital admission for children with bronchiolitis. Pneumologie 2008;62(2):63-4.
59. Kitowicz A, Criswell DF. Do inhaled corticosteroids improve oxygen saturation in infants with respiratory syncytial virus (RSV) bronchiolitis?. Journal of the Oklahoma State Medical Association 2007;100(7):266.
60. Koumbourlis AC. Oral corticosteroids in children with wheezing. New England Journal of Medicine 2009;360(16):1673.
61. Leer JA, Bloomfield N, Green JL, Heimlick EM, Hyde JS, Moffett HL, et al.Corticosteroids treatment in bronchiolitis. American Journal of Diseases of Children 1969;117(5):495-503.
62. Leer JA. Corticosteroids in bronchiolitis. JAMA 1969;208(6):1016-7.
63. Lin YZ, Hsieh KH, Chen W, Wu KW. Clinical trial of corticosteroid and beta-2 bronchodilator in acute wheezing infants. Chung-Hua Min Kuo Hsiao Erh Ko i Hsueh Hui Tsa Chih 1991;32(6):333-40.
64. Lukkarinen M, Lukkarinen H, Vuorinen T, Tuomas J. Prednisolone treatment of the first wheezing episode associated with rhinovirus infection reduces asthma in a 5-year follow-up. Allergy: European Journal of Allergy and Clinical Immunology 2011;66(Suppl 94):157.
65. Mallol J, Munoz R, Puppo H, Ulloa V, Toro O, Girardi G, et al.Effects of nebulized fenoterol, associated with ipratropium or glucocorticoids, on the heart rate of infants under one year of age with acute wheezing. Pediatric Pulmonology 1987;3(2):83-5.
66. Martini ABC. Viral respiratory tract infection: oral glucocorticoids not effective in wheezing children. Virale Atemwegsinfektioneh: orale glucocorticoide bei kindern mit giemen nicht effektiv 2009;149:40-1.
67. Merkus PJFM, de Jongste JC, Teper AM, Kofman CD, Vidaurreta SM. Inhaled corticosteroids in wheezy infants. American Journal of Respiratory and Critical Care Medicine 2005;172(8):1058-9.
68. Milner AD. The role of corticosteroids in bronchiolitis and croup. Thorax 1997;52(7):595-7.
69. O'Callaghan C, Milner AD. Inhaled glucocorticoids and recurrent wheeze after bronchiolitis. Lancet 1989;333(8652):1458.
70. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 2003;362(9394):1433-8.
71. Oski FA, Salitsky S, Barness LA. Steroid therapy in bronchiolitis: a double-blind study. American Journal of Diseases of Children 1961;102:759-64.
72. Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, et al.Oral prednisolone for preschool children with acute virus-induced wheezing. New England Journal of Medicine 2009;360(4):329-38.
73. Park J. The effect of salbutamol and budesonide inhalation therapy in infants with bronchiolitis. Journal of the Korean Pediatric Society 1997;40(1):45-54.
74. Patel H, Platt R, Lozano JM, Wang EE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD004878.pub2]
75. Patel H, Plint AC, Johnson DW, Wiebe N, Correll R, Brant R, et al.A multicenter randomized controlled trial of nebulized epinephrine and dexamethasone in outpatients with bronchiolitis. Paediatrics and Child Health 2008;13(Suppl A):Abstract 136.
76. Plint AC, Johnston DM, Patel H, Wiebe N, Correll R, Mitton C, et al.A multicenter randomized controlled trial of nebulized epinephrine and dexamethasone in outpatients with bronchiolitis. Academic Emergency Medicine 2008;15(5 Suppl 1):37.
77. Poets CF. Review: corticosteroids do not reduce hospital length of stay or respiratory distress in infantile acute viral bronchiolitis. Evidence-Based Medicine 2005;10(1):20.
78. Principi T, Komar L. KiDrug alert journal club. Canadian Journal of Clinical Pharmacology 2011;18:e273-4.
79. Rajeshwari K. Corticosteroid therapy for wheezy infants. Indian Pediatrics 2006;4(7):662.
80. Ranganathan SC, McKenzie SA. The use of corticosteroids in syntomathic asthma in childhood. Minerva Pediatrica 2003;55(4):357-67.
81. Renzi PM, Marcotte JE, Berube D, Bjornson C, Spier S. Effect of nebulized budesonide for 10 weeks on the development of asthma after acute bronchiolitis in infants. Proceedings of the American Thoracic Society 99th International Conference, 2003 May 16-21, Seattle WA. 2003:B012.
82. Sammartino L. Budesonide in acute bronchiolitis. Journal of Paediatrics and Child Health 1995;31(1):61-2.
83. Sano F, Cortez GK, Sole D, Naspitz CK. Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone. Journal of Allergy & Clinical Immunology 2000;105(4):699-703.
84. Schuh S, Coates AL, Binnie R. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. In: Paediatric emergency research in Canada: using the iterative loop as a research paradigm for advancing the field. Paediatrics and Child Health 2004;9(6):395-402.
85. Schuh S, Coates AL, Dick P, Stephens D, Lalani A, Nicota E, et al.A single versus multiple doses of dexamethasone in infants wheezing for the first time. Pediatric Pulmonology 2008;43(9):844-50.
86. Smart BA. Oral prednisolone for preschool children with acute virus-induced wheezing. Pediatrics 2009;124(Suppl):151.
87. Smith J, Salinas R. Do systemic corticosteroids improve acute outcomes in infants with RSV bronchiolitis?. Journal of the Oklahoma State Medical Association 2008;101(1):14.
88. Spencer DA, Gleeson JG, Price JF. Inhaled budesonide for acute wheeze in infants. Lancet 1989;1(8639):665.
89. Springer C, Bar-Yishay E, Uwayyed K, Avital A, Vilozni D, Godfrey S. Corticosteroids do not affect the clinical or physiological status of infants with bronchiolitis. Pediatric Pulmonology 1990;9:181-5.
90. Sussman S, Grossman M, Magoffin R, Schieble J. Dexamethasone (16-alpha-methyl, 9-alpha-flouroprednisolone) in obstructive respiratory tract infections in children. A controlled study. Pediatrics 1964;34:851-5.
91. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983;71(1):13-8.
92. Tofts RPH. Steroids do not improve RSV-related wheeze in children. Thorax 2009;64(9):769.
93. Uhereczky G, Gács É, Jákly A, Göndöcs R. Inhaled corticosteroids in atopic wheezy infants. Proceedings of the International Paediatric Respiratory and Allergy Congress 2001, April 1-4, Prague. 2001:84.
94. Van Bever HP. Corticosteroids for bronchiolitis. Lancet 1996;348(9029):753-4.
95. van Woensel JBM, Wolfs TFW, van Aalderen WMC, Brand PLP, Kimpen JLL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997;52:634-7.
96. van Woensel JB, Kimpen JL, Sprikkelman AB, Ouwehand A, van Aalderen WM. Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus. Pediatric Pulmonology 2000;30(2):92-6.
97. Van Woensel JBM, Van-Aalderen WMC, DeWeerd W, Jansen NJG, Van-Gestel JPJ, Markhorst DG, et al.Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax 2003;58(5):383-7.
98. Van Woensel JBM, Lutter R, Biezeveld MH, Dekker T, Nijhuis M, Van Aalderen WMC, et al.Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection. Pediatric Infectious Disease Journal 2003;22(8):721-6.
99. van Woensel JBM, Vyas H, Group Star Trial. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. Critical Care Medicine 2011;39:1779-83.
100. Wardrope J. Journal scan: randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Journal of Accident and Emergency Medicine 2000;17(5):368-70.
101. Webb MS, Henry RL, Milner AD. Oral corticosteroids for wheezing attacks under 18 months. Archives of Disease in Childhood 1986;61(1):15-9.
102. Weinberger M, Ahrens R. Oral prednisolone for viral wheeze in young children. Lancet 2004;363(9405):330-1.
103. Weinberger MM. High-dose systemic corticosteroids may be effective early in the course of bronchiolitis. Pediatrics 2007;119(4):864-5.
104. Wong JY, Moon S, Beardsmore C, O'Callaghan C, Simpson H. No objective benefit from glucocorticoids inhaled via a spacer in infants recovering from bronchiolitis. European Respiratory Journal 2000;15(2):388-94.
105. Yaffe SJ, Weiss CF. Committee on drugs. Should glucocorticoids be used in treating bronchiolitis?. Pediatrics 1970;46(4):640-2.
106. Zhu YF, Cai XH, Zhu JY, Jiang WP, Lan JH, Liu S. Study of CD4+ CD25+ regulatory T cells and expression of Foxp3 mRNA in bronchiolitis and glucocorticoid regulation. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal] 2009;89:1563-6.
107. Zuerlein N. Efficacy of combined corticosteroid (CS) and beta-agonist (BA) therapy for treatment of bronchiolitis in infants. Annals of Allergy 1990;64:85.
108. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774-93.
109. Babl FE, Sheriff N, Neutze J, Borland M, Oakley E. Bronchiolitis management in pediatric emergency departments in Australia and New Zealand: a PREDICT study. Pediatric Emergency Care 2008;24:656-8.
110. Barben JU, Robertson CF, Robinson PJ. Implementation of evidence-based management of acute bronchiolitis. Journal of Paediatrics and Child Health 2000;36:491-7.
111. Barben J, Hammer J. Current management of acute bronchiolitis in Switzerland. Swiss Medical Weekly 2003;133:9-15.
112. Barben J, Kuehni CE, Trachsel D, Hammer J. Management of acute bronchiolitis: can evidence based guidelines alter clinical practice?. Thorax 2008;63:1103-9.
113. Baumer JH. SIGN guideline on bronchiolitis in infants. Archives of Disease in Childhood Education and Practice 2007;92:ep149-51.
114. Bialy L, Foisy M, Smith M, Fernandes RM. The Cochrane Library and the treatment of bronchiolitis in children: an overview of reviews. Evidence-Based Child Health: A Cochrane Review Journal 2011;6(1):258-75.
115. Bjornson CL, Johnson DW. Croup. Lancet 2008;371(9609):329-39. [PUBMED: 18295000]
116. Black JL, Oliver BG, Roth M. Molecular mechanisms of combination therapy with inhaled corticosteroids and long-acting beta-agonists. Chest 2009;136(4):1095-100. [PUBMED: 19809050]
117. Boluyt N, Tjosvold L, Lefebvre C, Klassen TP, Offringa M. Usefulness of systematic review search strategies in finding child health systematic reviews in MEDLINE. Archives of Pediatrics & Adolescent Medicine 2008;162(2):111-6.
118. Bont L. Current concepts of the pathogenesis of RSV bronchiolitis. Advances in Experimental Medicine and Biology 2009;634:31-40. [PUBMED: 19280846]
119. Brand PL, Vaessen-Verberne AA. Differences in management of bronchiolitis between hospitals in The Netherlands. Dutch Paediatric Respiratory Society. European Journal of Pediatrics 2000;159:343-7.
120. Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, et al.Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. European Respiratory Journal 2008;32:1096-110.
121. Bush A, Thomson AH. Acute bronchiolitis. BMJ 2007;335:1037-41.
122. Bush A. Practice imperfect--treatment for wheezing in preschoolers. New England Journal of Medicine 2009;360:409-10.
123. Calvo C, Pozo F, Garcia-Garcia M, Sanchez M, Lopez-Valero M, Perez-Brena P, et al.Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatrica 2010;99:1651-2227 (Electronic).
124. Carroll KN, Gebretsadik T, Griffin MR, Wu P, Dupont WD, Mitchel EF, et al.Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics 2008;122:58-64.
125. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. American Journal of Respiratory and Critical Care Medicine 2000;162:1403-6. [PUBMED: 11029352]
126. Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics 2005;115:878-84.
127. Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. Journal of Virology 2008;82(5):2040-55. [PUBMED: 17928346]
128. Colosia AD, Masaquel A, Hall CB, Barrett AM, Mahadevia PJ, Yogev R. Residential crowding and severe respiratory syncytial virus disease among infants and young children: a systematic literature review. BMC Infectious Diseases 2012;12:95. [PUBMED: 22520624]
129. Damore D, Mansbach JM, Clark S, Ramundo M, Camargo CA Jr. Prospective multicenter bronchiolitis study: predicting intensive care unit admissions. Academic Emergency Medicine 2008;15:887-94.
130. David M, Luc-Vanuxem C, Loundou A, Bosdure E, Auquier P, Dubus JC. Assessment of the French Consensus Conference for Acute Viral Bronchiolitis on outpatient management: progress between 2003 and 2008. Archives Pediatrie 2010;17:125-31.
131. DiFranza JR, Masaquel A, Barrett AM, Colosia AD, Mahadevia PJ. Systematic literature review assessing tobacco smoke exposure as a risk factor for serious respiratory syncytial virus disease among infants and young children. BMC Pediatrics 2012;12:81. [PUBMED: 22721493]
132. DiTraglia J. Bronchiolitis. Archives of Pediatrics and Adolescent Medicine 2004; Vol. 158, issue 7:707; author reply 707-8. [PUBMED: 15237074]
133. Doyle LW, Ehrenkranz RA, Halliday HL. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 2010;98(4):289-96. [PUBMED: 20453523]
134. Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et al.Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. New England Journal of Medicine 2009;360:339-53.
135. Everard ML. Acute bronchiolitis and croup. Pediatric Clinics of North America 2009;56:119-xi.
136. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jimenez J, Fernandez-Colomer B, Guzman-Cabanas J, Echaniz-Urcelay I, et al.FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatric Infectious Disease Journal 2008;27:788-93.
137. Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100:233-9. [PUBMED: 9240805]
138. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of Clinical Epidemiology 1992;45:769-73.
139. Frey U, von Mutius E. The challenge of managing wheezing in infants. New England Journal of Medicine 2009; Vol. 360, issue 20:2130-3. [PUBMED: 19439749]
140. Giembycz MA, Kaur M, Leigh R, Newton R. A holy grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. British Journal of Pharmacology 2008;153(6):1090-104. [PUBMED: 18071293]
141. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94:130-6.
142. Glasziou PP, Shepperd S, Brassey J. Can we rely on the best trial? A comparison of individual trials and systematic reviews. BMC Medical Research Methodology 2010;10:23. [PUBMED: 20298582]
143. Gonzalez de Dios J, Ochoa Sangrador C. Study of variability in the management of acute bronchiolitis in Spain in relation to age of patients. National multicenter study (aBREVIADo project). Anales de Pediatría (Barcelona, Spain: 2003) 2010;72:4-18.
144. The GRADE Working Group. GRADE handbook for grading quality of evidence and strength of recommendation Version 3.2. Available from www.gradeworkinggroup.org 2009.
145. Guilbert TW, Bacharier LB. Controversies in the treatment of the acutely wheezing infant. American Journal of Respiratory and Critical Care Medicine 2011;183(10):1284-5.
146. Gurusamy KS, Gluud C, Nikolova D, Davidson BR. Design of surgical randomized controlled trials involving multiple interventions. Journal of Surgical Research Vol. 2009 Oct 30 [E-pub ahead of print]. [PUBMED: 20097373]
147. Halfhide C, Smyth RL. Innate immune response and bronchiolitis and preschool recurrent wheeze. Paediatric Respiratory Reviews 2008;9(4):251-62. [PUBMED: 19026366]
148. Hall CB. Therapy for bronchiolitis: when some become none. New England Journal of Medicine 2007;357:402-4.
149. Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al.Epinephrine for bronchiolitis. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD003123.pub3]
150. Hartling L, Fernandes RM, Bialy L, Milne A, Johnson D, Plint A, et al.Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ 2011;342:d1714.
151. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org 2011.
152. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al.Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. American Journal of Respiratory and Critical Care Medicine 2008;178(7):667-72. [PUBMED: 18565953]
153. Karemaker R, Karemaker JM, Kavelaars A, Tersteeg-Kamperman M, Baerts W, Veen S, et al.Effects of neonatal dexamethasone treatment on the cardiovascular stress response of children at school age. Pediatrics 2008;122(5):978-87. [PUBMED: 18977976]
154. Karemaker R, Kavelaars A, ter Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, et al.Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age. Pediatrics 2008;121(4):e870-8. [PUBMED: 18381516]
155. Kaur M, Chivers JE, Giembycz MA, Newton R. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Molecular Pharmacology 2008;73(1):203-14. [PUBMED: 17901197]
156. King VJ, Viswanathan M, Bordley WC, Jackman AM, Sutton SF, Lohr KN, et al.Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Archives of Pediatrics & Adolescent Medicine 2004;158:127-37.
157. Klassen TP. Determining the benefit of bronchodilators in bronchiolitis. When is there enough benefit to warrant adoption into clinical practice?. Archives of Pediatrics & Adolescent Medicine 1996; Vol. 150, issue 11:1120-1. [PUBMED: 8904850]
158. Koehoorn M, Karr CJ, Demers PA, Lencar C, Tamburic L, Brauer M. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics 2008;122:1196-203.
159. Korppi M. Are responses to treatment virus-specific in wheezing children?. Journal of Allergy and Clinical Immunology 2007; Vol. 119, issue 6:1561-2. [PUBMED: 17412400]
160. Kusel MM, de Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatric Infectious Disease Journal 2006;25:680-6.
161. Langley JM, Wang EE, Law BJ, Stephens D, Boucher FD, Dobson S, et al.Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. Journal of Pediatrics 1997;131:113-7.
162. Langley JM, LeBlanc JC, Smith B, Wang EE. Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000. Journal of Infectious Diseases 2003;188:1764-7.
163. Leer JA Jr, Green JL, Heimlich EM, Hyde JS, Moffet HL, Young GA, et al.Corticoglucocorticoid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children. American Journal of Diseases of Children 1969;117:495-503.
164. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. Chichester, UK: Wiley-Blackwell, 2011.
165. Lehtinen P, Ruohola A, Vanto T, Vuorinen T, Ruuskanen O, Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. Journal of Allergy and Clinical Immunology 2007;119(3):570-5. [PUBMED: 17196244]
166. Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics 1987;79(6):939-45. [PUBMED: 3295741]
167. Mallory MD, Shay DK, Garrett J, Bordley WC. Bronchiolitis management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics 2003;111:e45-51.
168. Mansbach JM, Emond JA, Camargo CA Jr. Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation. Pediatric Emergency Care 2005;21:242-7.
169. Mansbach JM, Pelletier AJ, Camargo CA Jr. US outpatient office visits for bronchiolitis, 1993-2004. Ambulatory Pediatrics 2007;7:304-7.
170. Mansbach JM, Camargo CA Jr. Bronchiolitis: lingering questions about its definition and the potential role of vitamin D. Pediatrics 2008;122:177-9.
171. Mansbach JM, McAdam AJ, Clark S, Hain PD, Flood RG, Acholonu U, et al.Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Academic Emergency Medicine 2008;15(2):111-8.
172. Mansbach JM, Piedra PA, Teach SJ, Sullivan AF, Forgey T, Clark S, et al.Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Archives of Pediatrics & Adolescent Medicine 2012; Vol. 166:8.
173. Martinez FD. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proceedings of the American Thoracic Society 2005;2:157-61.
174. McAlister FA, Straus SE, Sackett DL, Altman DG. Analysis and reporting of factorial trials: a systematic review. JAMA 2003;289:2545-53.
175. Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatric Infectious Disease Journal 2003;22(Suppl):40-4.
176. Miyairi I, DeVincenzo JP. Human genetic factors and respiratory syncytial virus disease severity. Clinical Microbiology Reviews 2008;21:686-703.
177. Montgomery AA, Peters TJ, Little P. Design, analysis and presentation of factorial randomised controlled trials. BMC Medical Research Methodology 2003;3:26.
178. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al.Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545-55.
179. Onland W, De Jaegere AP, Offringa M, van Kaam AH. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis. Pediatrics 2008;122(1):92-101. [PUBMED: 18595991]
180. Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al.AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions-agency for healthcare research and quality and the effective health-care program. Journal of Clinical Epidemiology 2010;63:513-23.
181. Papadopoulos NG, Moustaki M, Tsolia M, Bossios A, Astra E, Prezerakou A, et al.Association of rhinovirus infection with increased disease severity in acute bronchiolitis. American Journal of Respiratory and Critical Care Medicine 2002;165(9):1285-9.
182. Paramore LC, Ciuryla V, Ciesla G, Liu L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 2004;22:275-84.
183. Pelletier AJ, Mansbach JM, Camargo CA Jr. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006;118:2418-23.
184. Perez-Yarza EG, Moreno A, Lazaro P, Mejias A, Ramilo O. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatric Infectious Disease Journal 2007;26:733-9.
185. Plint AC, Johnson DW, Wiebe N, Bulloch B, Pusic M, Joubert G, et al.Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Academic Emergency Medicine 2004;11:353-60.
186. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
187. Robbins JM, Kotagal UR, Kini NM, Mason WH, Parker JG, Kirschbaum MS. At-home recovery following hospitalization for bronchiolitis. Ambulatory Pediatrics 2006;6:8-14.
188. Schuh S, Canny G, Reisman JJ, Kerem E, Bentur L, Petric M, et al.Nebulized albuterol in acute bronchiolitis. Journal of Pediatrics 1990;117(4):633-7. [PUBMED: 2213394]
189. Schultz A, Devadason SG, Savenije OE, Sly PD, Le Souef PN, Brand PL. The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatrica 2010;99(1):56-60. [PUBMED: 19764920]
190. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-6.
191. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. Journal of Pediatrics 2003;143:S118-26.
192. Simoes EA. RSV disease in the pediatric population: epidemiology, seasonal variability, and long-term outcomes. Managed Care 2008;17:3-6, discussion.
193. Simpson A, Tan VY, Winn J, Svensen M, Bishop CM, Heckerman DE, et al.Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. American Journal of Respiratory and Critical Care Medicine 2010;181(11):1200-6. [PUBMED: 20167852]
194. Singh AM, Moore PE, Gern JE, Lemanske RF Jr, Hartert TV. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. American Journal of Respiratory and Critical Care Medicine 2007;175:108-19.
195. Sly PD, Boner AL, Bjorksten B, Bush A, Custovic A, Eigenmann PA, et al.Early identification of atopy in the prediction of persistent asthma in children. Lancet 2008;372(9643):1100-6. [PUBMED: 18805338]
196. Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma?. Journal of Allergy and Clinical Immunology 2010;125:1202-5.
197. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006;368:312-22.
198. Somers CC, Ahmad N, Mejias A, Buckingham SC, Carubelli C, Katz K, et al.Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial. Pediatric Allergy and Immunology 2009;20(5):477-85. [PUBMED: 19397752]
199. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al.Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354(9178):541-5. [PUBMED: 10470697]
200. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics 1983;71(1):13-8. [PUBMED: 6129609]
201. Taussig LM, Landau LI. Pediatric Respiratory Medicine. Philadelphia: Mosby - Elsevier, 2008.
202. Turner T, Wilkinson F, Harris C, Mazza D. Evidence based guideline for the management of bronchiolitis. Australian Family Physician 2008;37:6-13.
203. van Woensel JB, van Aalderen WM, Kneyber MC, Heijnen ML, Kimpen JL. Bronchiolitis hospitalisations in the Netherlands from 1991 to 1999. Archives of Disease in Childhood 2002;86:370-1.
204. Weinberger M. Corticosteroids for first-time young wheezers: current status of the controversy. Journal of Pediatrics 2003; Vol. 143, issue 6:700-2. [PUBMED: 14657809]
205. Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. American Journal of Diseases of Children 1978;132(5):484-7. [PUBMED: 347921]
206. Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ. A systematic review identifies a lack of standardization in methods for handling missing variance data. Journal of Clinical Epidemiology 2006;59:342-53.
207. Wilson-Costello D, Walsh MC, Langer JC, Guillet R, Laptook AR, Stoll BJ, et al.Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics 2009;123(3):e430-7. [PUBMED: 19204058]
208. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. The Tucson Children's Respiratory Study. II. Lower respiratory tract illness in the first year of life. American Journal of Epidemiology 1989;129:1232-46.
209. Yusuf S, Piedimonte G, Auais A, Demmler G, Krishnan S, Van Caeseele P, et al.The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiology and Infection 2007;135:1077-90.
210. Zhang L, Sanguebsche LS. The safety of nebulization with 3 to 5 ml of adrenaline (1:1000) in children: an evidence based review [Seguranca de nebulizacao com 3 a 5 ml de adrenalina (1:1000) em criancas: uma revisao baseada em evidencia]. Jornal de Pediatria 2005;81(3):193-7. [PUBMED: 15951902]
211. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD006458.pub2]
212. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al.Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD004878.pub3]
213. Patel H, Platt R, Lozano JM, Wang EEL. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD004878.pub2]